Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

SHE:002755 Revenue

Beijing Aosaikang Pharmaceutical had revenue of 376.62M CNY in the quarter ending September 30, 2026, a decrease of -11.69%. This brings the company's total for the last twelve months to 1.59B, down -12.82% year-over-year. In the year 2025, Beijing Aosaikang Pharmaceutical had annual revenue of 1.78B with 0.08% growth. That makes Beijing Aosaikang Pharmaceutical the 16,205th largest company in the world by revenue and 2,930th in China.

• Revenue (ttm): 1.59B
• Revenue Growth: -12.82%
• P/S Ratio: 7.38
• Revenue / Employee: 1.99M
• Employees: 799
• Market Cap: 11.75B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Anti-Tumor 710.57M 39.9%
• Anti-infection 399.47M 22.5%
• Chronic Diseases 395.28M 22.2%
• Digestive 218.93M 12.3%
• Unallocated Other Operations 43.93M 2.5%
• Other Category 10.84M 0.6%

Fiscal year ended Dec 31, 2025 See the full SHE:002755 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.78B	1.38M	0.08%
Dec 31, 2024	1.78B	334.18M	23.15%
Dec 31, 2023	1.44B	-429.11M	-22.92%
Jan 1, 2023	1.87B	-1.23B	-39.72%
Jan 1, 2022	3.11B	-676.02M	-17.87%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error